Showing 1901-1910 of 4166 results for "".
- Midwest Vision Partners Announces Partnership With Cleveland Eye Clinichttps://modernod.com/news/midwest-vision-partners-announces-partnership-with-cleveland-eye-clinic/2477186/Eye care management company Midwest Vision Partners (MVP) has announced its partnership with Cleveland Eye Clinic (CEC). Terms of the deal were not disclosed. MVP’s partnership with CEC expands its network to 19 locations in Ohio with 33 physicians providing medical and surgic
- Pixium Vision Announces the Publication of Peer-Reviewed Clinical Data Demonstrating the Clinical Benefit of the Prima System in Dry AMD Patientshttps://modernod.com/news/pixium-vision-announces-the-publication-of-peer-reviewed-clinical-data-demonstrating-the-clinical-benefit-of-the-prima-system-in-dry-amd-patients/2480597/Pixium Vision SA announced the publication of a paper in Nature Communications outlining further data with its Prima System, a photovoltaic substitute of photoreceptors providing simultaneous use of the central prosthetic and peripheral natural vision in atrophi
- Heidelberg Engineering Names New Clinical Directorhttps://modernod.com/news/heidelberg-engineering-names-new-clinical-director/2478749/Steve Thomson has joined Heidelberg Engineering as Clinical Director to further strengthen the anterior segment product development team, according to a company news release. He will concentrate
- FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu Lens System in Patients with Cataractshttps://modernod.com/news/fda-grants-atia-vision-approval-to-begin-us-clinical-trial-of-omnivu-lens-system-in-patients-with-cataracts/2482811/Atia Vision has received Investigational Device Exemption (IDE) approval from the FDA to begin a traditional feasibility clinical study of its OmniVu Lens System. This novel IOL is designed to restore dynamic range of vision following catar
- Johnson & Johnson Vision to Launch Tecnis Synergy IOL and Showcase Latest Clinical Data at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs-2/2476873/Johnson & Johnson Vision will highlight key clinical data and the latest solutions in its growing portfolio of innovative products designed to improve vision care across generations at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) 2019 Annual Meeting in Paris, Fran
- Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs/2479857/Johnson & Johnson Vision highlighted key clinical data and latest solutions at the ESCRS meeting in Vienna. The company will offer a series of educational sessions for the ophthalmology community about the latest advancements in surgical vision, including diagnostic tools, available treatment
- IrisVision and Samsung Announce Partnership to Bring Clinically Validated Vision Technologies to Over 200 Million Low Vision Patients Globallyhttps://modernod.com/news/irisvision-and-samsung-announce-partnership-to-bring-clinically-validated-vision-technologies-to-over-200-million-low-vision-patients-globally/2477207/Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform uses the power of Samsung’s Galaxy smartphones, XR devices, and mobile AI platform to enable people
- Notal Vision: Clinical Trials Demonstrate Value of Home OCThttps://modernod.com/news/notal-vision-clinical-trials-demonstrate-value-of-home-oct/2481429/Notal Vision reported that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be used to manage wet age-related macular degeneration (AMD) were recently presented at the Angiogenesis, Exudation, and Degeneration and Macula Society 202
- Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to DME or RVOhttps://modernod.com/news/graybug-vision-initiates-clinical-trial-in-macular-edema-secondary-to-dme-or-rvo/2476898/Graybug Vision announced the initiation of its phase 2a study with GB-102 in patients with macular edema (ME) secondary to diabetic macular edema (DME) or retinal vein occlusion (RVO). GB-102, a pan-Vascular Endothelial Growth Factor (VEGF) inhibitor and potential twice-per-year therapy is
- The Vision Council Releases 2019 Vision Watch Cataract Reporthttps://modernod.com/news/the-vision-council-releases-2019-vision-watch-cataract-report/2478110/The Vision Council recently released the results of the 2019 VisionWatch Cataract Report. Conducted in December 2019, the study measures changes in consumer behavior related to vision and vision correction after undergoing cataract surgery. The intent of the study was to explore how cataract surg